Short interest in CVS Health Corp (NYSE:CVS) decreased during the last reporting period, falling from 19.88M to 18.26M. This put 1.45% of the company's publicly available shares short. Short ...

Baird raised the firm’s price target on CVS Health (CVS) to $71 from $51 and keeps a Neutral rating on the shares. The firm sees minimal ...

Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...